Frontier Airlines Conference Call Summary Company Overview - **Company**: Frontier Airlines (NasdaqGS:ULCC) - **Date of Conference**: March 17, 2026 Key Points Industry Comparison - **Comparison with Ryanair**: The CEO highlighted the structural profitability of Ryanair in Europe, attributing it to factors like country borders and language barriers, which do not exist in the U.S. market. The absence of credit card loyalty programs in Europe contrasts with the U.S. market, where legacy airlines have successfully leveraged such programs post-COVID [9][10][36]. Loyalty Program Development - **Loyalty Program Investment**: Frontier's loyalty program is described as immature, with plans to invest heavily in it to improve customer retention and cash flows. A 30% improvement in cash flows was noted in Q4, indicating the potential of loyalty programs to enhance financial performance [11][12]. - **Focus on Customer Retention**: The airline aims to create a stable revenue base through repeat customers and improved customer service metrics, such as on-time performance [19][50]. Fleet Management and Growth Strategy - **Fleet Right-Sizing**: The airline is transitioning from a growth rate of over 20% to a more modest growth rate in the high single digits, focusing on right-sizing the fleet in collaboration with AerCap and Airbus [13][15]. - **Cost-Saving Initiatives**: A $200 million cost-saving plan has been announced, with half of the savings expected from reduced rent due to the deal with AerCap [15][17]. Revenue Management - **Revenue Performance**: The airline has seen a 15% improvement in stage-length-adjusted revenue per available seat mile (RASM), attributed to disciplined pricing strategies and improved revenue management practices [67][68]. - **Booking Dynamics**: Frontier's demographic may be more sensitive to fuel prices, but the airline's steeper booking curve allows it to fill seats closer to departure dates, potentially aiding in fuel price recovery [73][78]. Competitive Landscape - **Impact of Spirit Airlines**: The overlap in capacity between Frontier and Spirit Airlines has significantly reduced, with Spirit's capacity dropping from over 200 aircraft to around 75-80. This reduction is expected to benefit Frontier by decreasing competition in overlapping markets [110][112]. - **Market Opportunities**: The airline is capitalizing on reduced capacity from competitors like Southwest and Spirit in key markets such as Atlanta and Las Vegas, allowing for growth in these regions [99][102]. Future Outlook - **Profitability Goals**: The CEO emphasized the focus on stabilizing revenue and lowering costs to return the airline to profitability. The airline aims to maintain its fleet size while improving productivity and revenue generation [129][140]. - **Fuel Price Management**: The airline is prepared to adapt its business model based on fluctuating fuel prices, with a strong starting point due to lower fuel burn per passenger compared to peers [78][88]. Additional Considerations - **Sale and Leaseback Strategy**: The CEO expressed a preference for a balanced approach to sale and leaseback financing, focusing on generating cash flow from operations rather than relying on upfront gains from these transactions [126][130]. - **Network Strategy**: The airline remains committed to operating in high-density coastal markets despite rising airport costs, recognizing the importance of these areas for profitability [90][94]. This summary encapsulates the key insights and strategic directions discussed during the Frontier Airlines conference call, highlighting the company's focus on loyalty, cost management, and market opportunities amidst a competitive landscape.

Verra Mobility Corporation Conference Call Summary Company Overview - **Company**: Verra Mobility Corporation - **Industry**: Tolling, Automated Enforcement, Smart Mobility Solutions - **Market Position**: Market leader in U.S. tolling and automated enforcement with over 90% recurring revenue [1][5] - **Financial Profile**: - Projected revenue for 2025: just under $1 billion - Service revenue: 94% of total revenue - Adjusted EBITDA: over $400 million - EBITDA margins: 42% - Free cash flow generation: approximately $137 million for the trailing twelve months ending 2025 [5][6] Business Segments 1. **Commercial Services**: - Accounts for about 45% of consolidated revenue - Market leader in toll and violation management for commercial fleets - Expected mid-single digit organic growth over the next few years - EBITDA margin in the mid-60s% [7][8] 2. **Government Solutions**: - Represents nearly half of the company - Industry leader in automated traffic enforcement for cities and school districts - High single-digit growth expected - EBITDA margins in the high 20s%, projected to improve by 2028 [8][9] 3. **Parking Solutions**: - Leading technology provider of end-to-end parking management solutions in North America - Focus on SaaS services and hardware without owning real estate [9] Capital Allocation Strategy - Total capital deployed since going public in 2018: approximately $2.5 billion - Priorities include: - Organic investments (CapEx primarily in government solutions) - Strategic M&A (approximately $1.2 billion spent since going public) - Debt repayment (around $200 million paid down) - Share buybacks (approximately $650 million since going public) [12][13] Cultural and Operational Insights - **Company Purpose**: To make transportation safer, smarter, and more efficient [22] - **Cultural Pillars**: - Do what's right - Courage over comfort - Win together - Emphasis on operational discipline and customer-centricity through a common operating system [24][32] Growth Strategies - **Volume Leverage**: Significant scalability across all business segments [46] - **Market Expansion**: Growth opportunities in government solutions and parking solutions, particularly in universities and small to medium cities [47] - **Innovation**: Focus on connected vehicle strategies and new market openings [47] Key Contracts and Opportunities - **New York City Contract**: - A $998 million contract for the next five years, with options for renewal - Largest deployment of photo enforcement technology globally - Expected to be EBITDA accretive despite some initial margin impacts due to expanded scope and pricing adjustments [50][52][58] - **California Opportunities**: - Expansion of photo enforcement technology and regulatory changes expected to generate significant revenue [91][93][96] Technology Platforms - **Mosaic Project**: Aims to consolidate legacy systems in government solutions, enhancing efficiency and unlocking value [80][85] - **Transition to SaaS**: Movement towards equipment-free deployments in the parking market, targeting a true SaaS business model [88][89] Investor Insights - **Recurring Revenue Model**: 94% of revenue is service-based, primarily recurring [124] - **Market Position**: Strong presence in photo enforcement and tolling, with significant growth potential in protecting vulnerable road users [130][131] - **Future Trends**: Anticipation of technological advancements in tolling and enforcement, positioning Verra Mobility for sustained growth [132][133]

Dover (NYSE:DOV) 2026 Conference Call Summary Company Overview - **Company**: Dover Corporation (NYSE:DOV) - **Date of Conference**: March 17, 2026 Key Industry Insights - **Macro Environment**: - Higher energy costs anticipated, primarily affecting freight costs, but not expected to pose significant hurdles [12][20] - Customer behavior remains stable with no immediate supply chain issues observed [12] Financial Performance and Guidance - **Order Trends**: - Strong order tracking reported for January and February, with expectations for a favorable book-to-bill ratio exceeding one by the end of Q1 [13][14] - Anticipation of a significant portion of Q2 booked by the end of Q1, but guidance revisions unlikely until further clarity is achieved [19][21] - **Organic Growth**: - Retail refrigeration impacted by previous year’s delays, with expectations for a gradual recovery rather than a sudden spike in volume [22] - CO2 platform projected to become a $300 million business, expected to drive significant growth in 2026 [23][25] Segment Performance - **Clean Energy & Fueling**: - Traditional retail gas station equipment showing positive growth after years of under-investment, with expectations for a three-year growth cycle [26][27] - Cryogenic components expected to maintain strong growth, contributing to margin improvements [27] - **Data Centers and Space**: - Notable growth in data center business, with a doubling of demand, and potential growth from cryogenic fuel supply for space launches [43][32] - **Retail Refrigeration**: - CO2 adoption rates accelerating, with significant long-term growth potential as major grocery chains transition to CO2 systems [40] - **Heat Pumps**: - Double-digit growth observed, albeit from a low base, with data center demand being a key driver [41][43] - **Engineered Products**: - Vehicle service segment performing well despite a down year in top-line growth, with military business expected to perform strongly [46][48] Margin and Cost Management - **EBITDA Margins**: - Targeting 25% EBITDA margin in Clean Energy & Fueling, with expectations for stable margins in other segments [83][92] - Focus on maintaining margins despite fluctuations in revenue and product mix [85][90] - **Raw Material Costs**: - Anticipated price increases of 1.5%-2% due to inflation, with a focus on managing copper pricing effectively [105][106] Capital Allocation and M&A Strategy - **Capital Return vs. M&A**: - Current bias towards a 50/50 split between capital return and M&A, with a focus on acquiring assets that align with existing platforms [117][118] - Interest in opportunities arising from private equity, with a cautious approach to complexity in the portfolio [123][125] Conclusion - **Outlook**: - Overall positive sentiment regarding growth prospects across various segments, with a focus on maintaining operational efficiency and strategic capital allocation [81][82] - **Market Position**: - Strong balance sheet positioned to capitalize on market dislocations and potential M&A opportunities [111][117]

Summary of J.B. Hunt Transport Services Conference Call Company Overview - **Company**: J.B. Hunt Transport Services (NasdaqGS: JBHT) - **Date of Conference**: March 17, 2026 - **Key Speakers**: Brad Delco (CFO), Darren Field (President of Intermodal), Greer Woodruff (EVP of Safety, Sustainability, and Maintenance) Key Industry Insights Demand and Supply Chain Dynamics - Demand was slightly stronger than expected in January, with some customers increasing their forecasts for the year, while others remained unchanged [2][3] - A significant winter storm at the end of January disrupted transportation supply chains, described as the worst event in a decade, impacting the ability to move equipment [3][4] - Rail service has improved significantly, with exceptional recovery from winter events, indicating a strong commitment from railroads to sustain resiliency [19][20] Market Conditions - The market is described as fragile, with limited elasticity in supply and demand dynamics, making it sensitive to disruptions [23][24] - Customers are managing inventories more confidently, operating with lower levels due to the reliable supply chain, but there is concern about potential lost sales if demand increases unexpectedly [35][36] Regulatory Environment - The administration is enforcing existing rules more strictly, which could lead to a reduction of 5% to 12% of CDL holders over the next few years due to non-compliance [41][43] - Changes in training standards for truck driving schools are anticipated, with a focus on improving the quality of new entrants into the industry [44][45] Company Strategy and Performance Intermodal Strategy - The company is focusing on converting highway freight to intermodal to help customers save costs, especially in a rising fuel price environment [25][26] - Intermodal fuel surcharges are typically lower than truckload surcharges, providing a competitive advantage [30][31] Cost Management and Efficiency - The company is actively working on cost-to-serve initiatives to improve margins and operational efficiency, with a focus on technology and process improvements [69][75] - The goal is to repair margins while managing inflationary pressures, with a commitment to transparency in reporting progress to investors [76][79] Future Outlook - The company anticipates a competitive environment where all players are focused on revenue recovery and margin repair, with intermodal pricing expected to lag behind truckload pricing historically [58][59] - There is an emphasis on collaboration with customers to optimize service and reduce costs, moving away from a zero-sum pricing strategy [66][67] Additional Considerations - The company is preparing for potential changes in the regulatory landscape, including the implications of the DRIVE-Safe Act and its impact on the brokerage business [50][52] - The focus on technology as a key enabler for operational efficiency and capacity utilization is central to the company's long-term strategy [80]

Bakkt I (NYSE:BKKT) 2026 Investor Day March 17, 2026 09:30 AM ET Company ParticipantsAkshay Naheta - CEOAnkit Khemka - Chief Product OfficerCody Fletcher - Investor Relations AdvisorKaren Alexander - CFONick Baes - COORémi Tuyaerts - CTOConference Call ParticipantsDillon Heslin - AnalystMarnie Lysaght - AnalystNone - AnalystCody FletcherGood morning.Akshay NahetaGood morning.Cody FletcherThanks everybody for coming today to Bakkt's first Investor Day, both here in person and virtually at homes or in your of ...

Alcoa (NYSE:AA) 2026 Conference Summary Company Overview - Alcoa is an integrated aluminum company with a revenue of just under $13 billion in 2025 - Organized into two segments: alumina and aluminum - Operates five bauxite mines and five alumina refineries, producing approximately 40 million metric tons of bauxite and 10 million metric tons of alumina annually - Consumes about 40% of its produced alumina in its aluminum business, which includes eleven smelters primarily located near customer markets - Operates on 86% renewable energy, minimizing energy exposure through long-term contracts [2][3] Financial Performance and Outlook - Strong start to 2026 with stable operations and strategic initiatives in place - Recent agreements in Australia led to a post-earnings adjustment charge of $19 million in Q4 2025, reducing the unfavorable outlook from $30 million to $11 million in Q1 2026 - Aluminum shipments expected to be 30,000 metric tons lower than anticipated, resulting in a revenue reduction of approximately $150 million for Q1 2026 [7][8] - Anticipated delay in EBITDA recognition of about $30 million due to inventory repositioning to the U.S. [8] - Revenue expected to be lower by approximately $60 million due to increases in LME and Midwest premium impacting metal-linked energy contracts [9] Market Dynamics - Middle East conflict affecting aluminum and alumina markets, with Gulf smelters producing just under 7 million metric tons of aluminum, representing about 9% of global supply [12][13] - Alba and Qatalum smelters have curtailed production, leading to higher LME prices and regional premiums [15] - Alcoa has long-term alumina supply contracts with EGA and ALBA, totaling about 4 million metric tons annually, which are impacted by the current supply situation [16] Demand and Order Book - Demand characterized as stable before the conflict, with strong markets in packaging, electrical, construction, and renewable energy infrastructure [18] - Increased inquiries from customers for Q2 and the second half of 2026 due to supply concerns from Middle East smelters [18] Operational Challenges and Improvements - Alumar smelter faced production instability due to power outages, currently operating at about 80% capacity [37] - Focus on continuous improvement in operations, with record production at five smelters and one refinery in 2025 [39] - San Ciprián smelter ramping up well, expected to reach full capacity by mid-2026 [41] Strategic Initiatives - Plans to monetize $500 million to $1 billion of assets by 2030, focusing on transformation sites with energy infrastructure [32] - Collaboration with governments for a gallium plant at the Wagerup refinery, expected to produce about 100 tons of gallium, representing nearly 10% of global supply [55][56] Capital Allocation and Financial Health - Reached the high end of adjusted net debt target of $1 billion to $1.5 billion by the end of 2025, with plans for further deleveraging [61] - Focus on balancing growth opportunities with returns to shareholders, ensuring any growth projects exceed the cost of capital [64] Environmental and Regulatory Considerations - Long-term contracts for natural gas and electricity provide security against price fluctuations [22] - Modernization of federal permitting processes in Australia to enhance mining operations through 2045 [48][49] Conclusion - Alcoa is positioned for a strong 2026, focusing on operational performance and strategic initiatives while navigating market uncertainties and geopolitical challenges [66][67]

Summary of Elanco Animal Health Conference Call Company Overview - **Company**: Elanco Animal Health - **Industry**: Animal Health Key Points Financial Performance - Elanco reported revenues of **$892 million** from its basket of innovation, exceeding the guidance of **$840-$880 million** for the year [2][3] - The revenue guidance for 2026 has been raised to **$1.15 billion** due to strong momentum [3] - The company expects **4%-6% organic constant currency growth**, **8% adjusted EBITDA growth**, and **10% adjusted EPS growth** for 2026 [10][11] Product Performance - **Credelio Quattro** and **Zenrelia** are key products driving growth, with Quattro being positioned as the best medicine in the parasiticides market, which is valued at **$1 billion** and growing at **30%** [3][4] - Zenrelia has achieved a **double-digit market share** in the U.S. and has expanded to **3,500 clinics** following a label update [4][21] - **Experior**, another product, generated revenues exceeding **$200 million** in 2025, growing **80%** in a total addressable market of **$350 million** [5][6] Market Dynamics - The company is monitoring the impact of geopolitical events, such as the conflict in Iran, but currently does not see a material impact on costs or supply chain [8] - The willingness to spend on pet health is increasing, with **one-third** of pet owners spending more on their pets' health than their own [33] Innovation and R&D - Elanco is focused on expanding its product pipeline, with over **10 potential blockbuster products** expected in the next decade [15][16] - The company is investing in **AI and automation** to enhance efficiency across various functions, including R&D and manufacturing [45][46] Strategic Initiatives - Elanco plans to continue pursuing **M&A** to enhance R&D capabilities while maintaining a focus on deleveraging [40][41] - The company is also expanding its geographic reach, with approvals for Quattro in Australia and submissions in Canada, the EU, UK, and Japan [27][28] Future Outlook - The company anticipates that the globalization of its products will be a key driver for long-term growth, with significant potential in international markets [28] - The launch of **Befrena** is expected in mid-2026, with a phased rollout planned [25][26] Operational Efficiency - Elanco Ascend is expected to contribute **$200 million-$250 million** in net EBIT improvement by 2030, with a focus on gross margin enhancement [55][56] - The company aims to achieve **$25 million** in savings this year from restructuring efforts, with a total expected benefit of **$60 million** by 2027 [57] Additional Insights - The competitive landscape is being closely monitored, with potential impacts from foreign exchange rates and competitive responses to Elanco's product success [12][13] - The company emphasizes the importance of a comprehensive portfolio to meet the evolving needs of pet owners [36][37]

Lifecore Biomedical Conference Call Summary Company Overview - **Company**: Lifecore Biomedical (NasdaqGS: LFCR) - **Industry**: Life Sciences, specifically focusing on Contract Development and Manufacturing Organization (CDMO) services - **Recent Changes**: Lifecore has divested its food business, transforming into a pure-play life sciences company, with the last divestiture occurring in 2023 [2][3] Business Segments - **Hyaluronic Acid Fermentation**: Produces sterile injectable grade hyaluronic acid for ophthalmic, orthopedic, and dermal applications [3] - **Contract Manufacturing**: Provides sterile injectable products for other pharmaceutical companies, focusing on development and commercial manufacturing [3] Financial Performance and Projections - **Revenue Guidance**: Mid-term revenue projections have been increased to $212-$225 million, reflecting confidence in business growth [5] - **Capacity Utilization**: Current capacity utilization is at 20%, expected to rise to 60% by 2029, with a target of 80% for a fully booked site [7][8] - **EBITDA Margin Target**: Aiming for greater than 25% EBITDA margin by 2029, with current margins at 17% [9][10] Growth Strategy - **Customer Demand**: Anticipation that the largest customer will more than double fill-finish demand starting in the next few years [10] - **Late-Stage Pipeline**: Currently has 10 programs in late-stage development, with a modest conversion rate of 50% expected [10] - **Business Development Strategy**: Shift from a farming approach to a more aggressive hunting strategy for new business opportunities, including biologics [11] Market Trends and Opportunities - **Reshoring**: Notable trend towards reshoring manufacturing to the U.S., with Lifecore benefiting from this shift [19] - **Tech Transfer Agreements**: Recently signed two major tech transfer agreements, potentially becoming top five customers, with expected annualized revenue exceeding $10 million [15][16] - **International Opportunities**: Plans to leverage existing networks for partnerships rather than establishing a physical presence overseas [36] Operational Updates - **ERP System Implementation**: Successfully launched a new ERP system, expected to improve productivity and financial management [26] - **Sales Team**: Currently has a sales team of seven, operating at 60%-70% capacity, with plans to ramp up activities [33] Competitive Positioning - **Pricing Strategy**: Lifecore competes on value rather than price, focusing on technical expertise and quality [22][23] - **Regulatory Track Record**: Strong regulatory history with no warning letters, enhancing credibility in the market [46] Conclusion - Lifecore Biomedical is positioned for growth with a clear strategy focused on expanding its CDMO capabilities, improving operational efficiency, and capitalizing on market trends such as reshoring and increased demand for biologics. The company is optimistic about its future, driven by a strong commercial base and a promising late-stage pipeline [48]

CACI International Conference Summary Company Overview - CACI International is a national security company based in Northern Virginia, with over 60 years of history and publicly held for about 50 years - 90% of revenues come from the national security sector of the U.S. government budget, with 60% from technology solutions and 40% from expertise services - The company has grown to a size of $9.4 billion with 27,000 employees, focusing on free cash flow per share growth as a measure of success [5][11][12] Differentiation Strategy - CACI differentiates itself from traditional defense services companies by focusing on software-based technology solutions rather than just labor hours [9][11] - The company has exited the "buy the hour" services business, emphasizing modernized technology solutions that drive free cash flow per share [11][12] - CACI's technology is software-defined, allowing for rapid adaptation to changing mission requirements, particularly in areas like drone warfare and electronic warfare [13][20] Market Position and Growth - The company has shifted its focus towards technology solutions, which now account for 60% of its business, up from 50% the previous year [18] - CACI has a unique position with 1,400 personnel co-located with combatant commanders, providing real-time insights into conflicts and technology effectiveness [19] - The total addressable market (TAM) has increased from $280 billion to $300 billion, driven by U.S. government spending in electronic warfare [33] Investment and Capital Deployment - CACI has a flexible and opportunistic capital deployment strategy, focusing on share repurchases and acquisitions rather than paying dividends [69][70] - The company has acquired ARKA, a significant asset that enhances its capabilities in electromagnetic spectrum operations [34][70] - CACI aims to maintain a debt-to-EBITDA ratio of 2.5-3 times, with plans to return to 3.1 or 3.2 in the next six quarters [70] Award Environment and Contract Strategy - The award environment has been slower to restart post-shutdown, but CACI has a strong backlog of approximately 3.5 years of revenue [52][53] - The company focuses on bidding for larger, longer-duration contracts, which helps stabilize revenue and reduces volatility [57][58] - CACI has embraced Other Transaction Agreements (OTAs) to facilitate quicker solutions and iterative development with customers [60] Challenges and Future Outlook - The company acknowledges the competitive landscape in the counter-drone market, emphasizing the importance of distance and decision time in countering threats [30] - CACI's approach to AI and technology is designed to enhance agility and speed in delivering solutions, with a focus on outcomes rather than inputs [41][42] - The company is well-positioned to capitalize on the growing demand for technology-driven solutions in national security, with a commitment to investing ahead of customer needs [29][48] Conclusion - CACI International is strategically positioned in the national security sector, focusing on technology solutions and expertise to drive growth and free cash flow - The company’s unique approach to capital deployment, contract bidding, and market differentiation sets it apart from traditional defense contractors, positioning it for continued success in a rapidly evolving landscape [11][12][33][48]

Summary of Schrödinger Conference Call Company Overview - **Company**: Schrödinger (NasdaqGS:SDGR) - **Industry**: Computational drug discovery and materials design Core Points and Arguments - **Mission**: Develop a computational platform for researchers in life sciences and materials science to design better molecules more efficiently, aiming to replace traditional trial-and-error methods in drug discovery [2][3] - **Platform Validation**: The platform has been validated over 15 years with a track record of success, including 15-16 programs in clinical stages and successful exits for co-founded biotech companies [4] - **Customer Retention**: The company boasts a 100% customer retention rate, indicating the platform's significant impact on projects [5] - **Market Potential**: The total addressable market (TAM) is projected to be much larger than the current $200 million annual revenue, with expectations for growth as more pharmaceutical companies adopt the technology [5][6] - **New Product Launch**: Introduction of "Predictive Tox," aimed at predicting toxicity in drug discovery, which is a significant challenge in the industry [6][7] Strategic Changes - **Business Structure Simplification**: The company is shifting focus from executing clinical programs independently to partnering with other firms, allowing for downstream milestones and royalties [9] - **Transition to Hosted Contracts**: A strategic pivot towards hosted contracts in the software business, moving from 25% to an expected 75% hosted contracts over three years, which may initially reduce revenue but aims for long-term stability [10][11] - **Financial Goals**: Aiming for adjusted EBITDA profitability within three years by growing both software and drug discovery businesses while maintaining expense discipline [9] Market Environment - **Funding Environment**: The company is optimistic about a 10%-15% growth in annual contract value (ACV) compared to a challenging previous year, with budget pressures in pharma and biotech easing [27][28] - **New Product Impact**: The release of new products, including Predictive Tox, is expected to unlock additional budgets and contribute to growth [31][34] Technology and Innovation - **Agentic AI Integration**: The company is embedding agentic AI into its platform to enhance efficiency and support more programs, aiming to make computational methods more accessible to a broader user base [49][50] - **Unique Technology Development**: The predictive toxicity technology is physics-based, allowing for early-stage application in drug discovery, which is expected to create a new sector and increase usage [39][40] Financial Model and Transition - **Revenue Recognition Changes**: Transitioning from on-premise to hosted solutions will lead to a shift in revenue recognition, with a focus on ACV as a key operating metric during the transition [60][63] - **Long-term Profitability**: The company expects to achieve profitability by 2028, with a smoother revenue profile as hosted contracts become the norm [58][64] Customer Engagement and Market Trends - **Increased Interest in Computation**: There is a growing demand for computational methods in drug discovery, driven by the excitement around AI and the need for large datasets to train AI models [72][73] - **Partnership Opportunities**: The company is open to M&A for complementary capabilities that align with its platform, although it will not venture into areas far removed from its core competencies [47][48] Conclusion - Schrödinger is positioned for growth through strategic pivots in its business model, innovative product offerings, and a strong focus on computational drug discovery, with a clear path towards profitability and market expansion in the coming years.